Do analysts recommend DCGO or JYNT?

DocGo currently has a consensus target price of $2.38, indicating a potential upside of 589.40%. Given DocGo's stronger consensus rating and higher possible upside, equities analysts plainly believe DocGo is more favorable than Joint. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Joint 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Which has stronger earnings & valuation, DCGO or JYNT?

Joint has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DocGo $322.20M 0.11 -$182.40M -$1.96 N/A Joint $54.90M 2.12 $2.91M $0.27 30.48

Is DCGO or JYNT more profitable?

Joint has a net margin of 6.49% compared to DocGo's net margin of -65.29%. Joint's return on equity of 12.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets DocGo -65.29% -40.42% -24.81% Joint 6.49% 12.02% 3.47%

Does the media prefer DCGO or JYNT?

In the previous week, DocGo had 1 more articles in the media than Joint. MarketBeat recorded 4 mentions for DocGo and 3 mentions for Joint. DocGo's average media sentiment score of 0.61 beat Joint's score of 0.60 indicating that DocGo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Joint 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer PARK or DCGO?

In the previous week, Park Dental Partners and Park Dental Partners both had 4 articles in the media. Park Dental Partners' average media sentiment score of 0.70 beat DocGo's score of 0.61 indicating that Park Dental Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Park Dental Partners 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DocGo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is DCGO or ACH more profitable?

Accendra Health has a net margin of -11.41% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets DocGo -65.29% -40.42% -24.81% Accendra Health -11.41% -4.02% 0.70%

Does the media refer more to DCGO or ACH?

In the previous week, DocGo had 3 more articles in the media than Accendra Health. MarketBeat recorded 4 mentions for DocGo and 1 mentions for Accendra Health. Accendra Health's average media sentiment score of 0.90 beat DocGo's score of 0.61 indicating that Accendra Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Accendra Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, PIII or DCGO?

P3 Health Partners has higher revenue and earnings than DocGo. P3 Health Partners is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio P3 Health Partners $1.46B 0.04 -$147.95M -$33.00 N/A DocGo $322.20M 0.11 -$182.40M -$1.96 N/A

Is PIII or DCGO more profitable?

P3 Health Partners has a net margin of -6.55% compared to DocGo's net margin of -65.29%. P3 Health Partners' return on equity of 0.00% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets P3 Health Partners -6.55% N/A -16.40% DocGo -65.29% -40.42% -24.81%

Does the media prefer PIII or DCGO?

In the previous week, DocGo had 2 more articles in the media than P3 Health Partners. MarketBeat recorded 4 mentions for DocGo and 2 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 0.91 beat DocGo's score of 0.61 indicating that P3 Health Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DocGo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate RYOJ or DCGO?

DocGo has a consensus target price of $2.38, suggesting a potential upside of 589.40%. Given DocGo's stronger consensus rating and higher probable upside, analysts plainly believe DocGo is more favorable than RYOJ. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 DocGo 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has stronger earnings & valuation, RYOJ or DCGO?

RYOJ has higher earnings, but lower revenue than DocGo. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RYOJ $9.34M 4.72 $120K N/A N/A DocGo $322.20M 0.11 -$182.40M -$1.96 N/A

Is RYOJ or DCGO more profitable?

RYOJ has a net margin of 0.00% compared to DocGo's net margin of -65.29%. RYOJ's return on equity of 0.00% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets RYOJ N/A N/A N/A DocGo -65.29% -40.42% -24.81%

Does the media favor RYOJ or DCGO?

In the previous week, DocGo had 2 more articles in the media than RYOJ. MarketBeat recorded 4 mentions for DocGo and 2 mentions for RYOJ. RYOJ's average media sentiment score of 0.91 beat DocGo's score of 0.61 indicating that RYOJ is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RYOJ 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DocGo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

DocGo (DCGO) Competitors

$0.34 +0.00 (+1.32%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$0.35 +0.00 (+0.44%)

As of 09/25/2026 07:28 PM Eastern

Compare

DCGO vs. JYNT, PARK, ACH, PIII, and RYOJ

Should you buy DocGo stock or one of its competitors? DocGo's main competitors and comparable companies include Joint (JYNT), Park Dental Partners (PARK), Accendra Health (ACH), P3 Health Partners (PIII), and RYOJ (RYOJ). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does DocGo compare to Joint?

DocGo (NASDAQ:DCGO) and Joint (NASDAQ:JYNT) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, DocGo had 1 more articles in the media than Joint. MarketBeat recorded 4 mentions for DocGo and 3 mentions for Joint. DocGo's average media sentiment score of 0.61 beat Joint's score of 0.60 indicating that DocGo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Joint	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Joint has a net margin of 6.49% compared to DocGo's net margin of -65.29%. Joint's return on equity of 12.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Joint	6.49%	12.02%	3.47%

56.4% of DocGo shares are owned by institutional investors. Comparatively, 76.9% of Joint shares are owned by institutional investors. 5.1% of DocGo shares are owned by company insiders. Comparatively, 30.2% of Joint shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Joint has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.11	-$182.40M	-$1.96	N/A
Joint	$54.90M	2.12	$2.91M	$0.27	30.48

DocGo has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market. Comparatively, Joint has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

DocGo currently has a consensus target price of $2.38, indicating a potential upside of 589.40%. Given DocGo's stronger consensus rating and higher possible upside, equities analysts plainly believe DocGo is more favorable than Joint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Joint	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

Joint beats DocGo on 10 of the 16 factors compared between the two stocks.

How does DocGo compare to Park Dental Partners?

Park Dental Partners (NASDAQ:PARK) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Park Dental Partners has higher earnings, but lower revenue than DocGo. DocGo is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Park Dental Partners	$244.49M	0.39	-$360K	$1.05	18.96
DocGo	$322.20M	0.11	-$182.40M	-$1.96	N/A

Park Dental Partners presently has a consensus target price of $28.50, indicating a potential upside of 43.14%. DocGo has a consensus target price of $2.38, indicating a potential upside of 589.40%. Given DocGo's higher probable upside, analysts plainly believe DocGo is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Park Dental Partners and Park Dental Partners both had 4 articles in the media. Park Dental Partners' average media sentiment score of 0.70 beat DocGo's score of 0.61 indicating that Park Dental Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Park Dental Partners	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

56.4% of DocGo shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by company insiders. Comparatively, 5.1% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Park Dental Partners has a net margin of 0.00% compared to DocGo's net margin of -65.29%. Park Dental Partners' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Park Dental Partners	N/A	N/A	N/A
DocGo	-65.29%	-40.42%	-24.81%

Summary

Park Dental Partners beats DocGo on 11 of the 15 factors compared between the two stocks.

How does DocGo compare to Accendra Health?

DocGo (NASDAQ:DCGO) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 589.40%. Accendra Health has a consensus target price of $1.50, suggesting a potential upside of 110.14%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts plainly believe DocGo is more favorable than Accendra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

In the previous week, DocGo had 3 more articles in the media than Accendra Health. MarketBeat recorded 4 mentions for DocGo and 1 mentions for Accendra Health. Accendra Health's average media sentiment score of 0.90 beat DocGo's score of 0.61 indicating that Accendra Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accendra Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

56.4% of DocGo shares are owned by institutional investors. 5.1% of DocGo shares are owned by insiders. Comparatively, 2.3% of Accendra Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

DocGo has higher earnings, but lower revenue than Accendra Health. Accendra Health is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.11	-$182.40M	-$1.96	N/A
Accendra Health	$2.73B	0.02	-$1.10B	-$3.91	N/A

Accendra Health has a net margin of -11.41% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Accendra Health	-11.41%	-4.02%	0.70%

DocGo has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market. Comparatively, Accendra Health has a beta of 1.53, meaning that its share price is 53% more volatile than the broader market.

Summary

DocGo beats Accendra Health on 10 of the 16 factors compared between the two stocks.

How does DocGo compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

7.8% of P3 Health Partners shares are owned by institutional investors. Comparatively, 56.4% of DocGo shares are owned by institutional investors. 10.9% of P3 Health Partners shares are owned by insiders. Comparatively, 5.1% of DocGo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, DocGo had 2 more articles in the media than P3 Health Partners. MarketBeat recorded 4 mentions for DocGo and 2 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 0.91 beat DocGo's score of 0.61 indicating that P3 Health Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

P3 Health Partners has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, DocGo has a beta of 0.94, meaning that its stock price is 6% less volatile than the broader market.

P3 Health Partners presently has a consensus price target of $17.00, suggesting a potential upside of 141.13%. DocGo has a consensus price target of $2.38, suggesting a potential upside of 589.40%. Given DocGo's stronger consensus rating and higher probable upside, analysts plainly believe DocGo is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

P3 Health Partners has a net margin of -6.55% compared to DocGo's net margin of -65.29%. P3 Health Partners' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-6.55%	N/A	-16.40%
DocGo	-65.29%	-40.42%	-24.81%

P3 Health Partners has higher revenue and earnings than DocGo. P3 Health Partners is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.04	-$147.95M	-$33.00	N/A
DocGo	$322.20M	0.11	-$182.40M	-$1.96	N/A

Summary

P3 Health Partners and DocGo tied by winning 8 of the 16 factors compared between the two stocks.

How does DocGo compare to RYOJ?

RYOJ (NASDAQ:RYOJ) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

RYOJ has a net margin of 0.00% compared to DocGo's net margin of -65.29%. RYOJ's return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RYOJ	N/A	N/A	N/A
DocGo	-65.29%	-40.42%	-24.81%

DocGo has a consensus target price of $2.38, suggesting a potential upside of 589.40%. Given DocGo's stronger consensus rating and higher probable upside, analysts plainly believe DocGo is more favorable than RYOJ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

56.4% of DocGo shares are held by institutional investors. 5.1% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, DocGo had 2 more articles in the media than RYOJ. MarketBeat recorded 4 mentions for DocGo and 2 mentions for RYOJ. RYOJ's average media sentiment score of 0.91 beat DocGo's score of 0.61 indicating that RYOJ is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RYOJ	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RYOJ has higher earnings, but lower revenue than DocGo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RYOJ	$9.34M	4.72	$120K	N/A	N/A
DocGo	$322.20M	0.11	-$182.40M	-$1.96	N/A

Summary

DocGo beats RYOJ on 7 of the 13 factors compared between the two stocks.

Get DocGo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DCGO vs. The Competition

Export

Metric	DocGo	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$34.08M	$9.82B	$7.34B	$13.18B
Dividend Yield	N/A	2.59%	2.52%	14.03%
P/E Ratio	-0.18	35.06	275.82	25.76
Price / Sales	0.11	5.01	619.96	85.79
Price / Cash	6.23	123.01	79.52	52.89
Price / Book	0.27	5.24	10.44	6.30
Net Income	-$182.40M	$315.70M	$3.51B	$360.35M
7 Day Performance	-4.09%	0.71%	-1.31%	-0.23%
1 Month Performance	-12.83%	-0.41%	-4.72%	-3.87%
1 Year Performance	-74.85%	16.63%	14.97%	5.38%

DocGo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DCGO DocGo	2.868 of 5 stars	$0.34 +1.3%	$2.38 +589.4%	-75.2%	$34.08M	$322.20M	N/A	3,568	News Coverage
JYNT Joint	1.6117 of 5 stars	$8.23 -0.7%	N/A	-16.4%	$116.37M	$54.90M	30.48	330
PARK Park Dental Partners	4.115 of 5 stars	$19.91 +1.5%	$28.50 +43.1%	N/A	$94.77M	$244.49M	18.96	1,212	Short Interest Increase High Trading Volume
ACH Accendra Health	1.7332 of 5 stars	$0.71 -2.6%	$1.50 +110.1%	N/A	$54.89M	$2.73B	N/A	6,500	News Coverage
PIII P3 Health Partners	3.7186 of 5 stars	$7.05 flat	$17.00 +141.1%	-30.8%	$51.18M	$1.46B	N/A	320	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DCGO) was last updated on 9/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DocGo (DCGO) Competitors

DCGO vs. JYNT, PARK, ACH, PIII, and RYOJ

How does DocGo compare to Joint?

Summary

How does DocGo compare to Park Dental Partners?

Summary

How does DocGo compare to Accendra Health?

Summary

How does DocGo compare to P3 Health Partners?

Summary

How does DocGo compare to RYOJ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCGO vs. The Competition

DocGo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DocGo (DCGO) Competitors

DCGO vs. JYNT, PARK, ACH, PIII, and RYOJ

How does DocGo compare to Joint?

Does the media prefer DCGO or JYNT?

Is DCGO or JYNT more profitable?

Do institutionals and insiders believe in DCGO or JYNT?

Which has stronger earnings & valuation, DCGO or JYNT?

Which has more volatility and risk, DCGO or JYNT?

Do analysts recommend DCGO or JYNT?

Summary

How does DocGo compare to Park Dental Partners?

Which has preferable earnings & valuation, PARK or DCGO?

Do analysts prefer PARK or DCGO?

Does the media prefer PARK or DCGO?

Do insiders & institutionals believe in PARK or DCGO?

Is PARK or DCGO more profitable?

Summary

How does DocGo compare to Accendra Health?

Do analysts recommend DCGO or ACH?

Does the media refer more to DCGO or ACH?

Do insiders & institutionals hold more shares of DCGO or ACH?

Which has better valuation & earnings, DCGO or ACH?

Is DCGO or ACH more profitable?

Which has more risk and volatility, DCGO or ACH?

Summary

How does DocGo compare to P3 Health Partners?

Do insiders & institutionals have more ownership in PIII or DCGO?

Does the media prefer PIII or DCGO?

Which has more risk & volatility, PIII or DCGO?

Do analysts rate PIII or DCGO?

Is PIII or DCGO more profitable?

Which has stronger valuation & earnings, PIII or DCGO?

Summary

How does DocGo compare to RYOJ?

Is RYOJ or DCGO more profitable?

Do analysts rate RYOJ or DCGO?

Do institutionals and insiders have more ownership in RYOJ or DCGO?

Does the media favor RYOJ or DCGO?

Which has stronger earnings & valuation, RYOJ or DCGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCGO vs. The Competition

DocGo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools